News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Syrrx, Inc. Researchers Report Atomic Structure Of c-KIT In Complex With Gleevec



10/19/2005 5:11:54 PM

Syrrx Inc., a next-generation, structure-based drug discovery company, today reported the publication of an article further describing the atomic structure of c-Kit kinase in complex with Novartis' cancer drug Gleevec(R) (also known as STI-571). Syrrx and Novartis are independently using the solved structure to design new anti-cancer agents.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES